Issued Patents All Time
Showing 1–25 of 58 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12336992 | PAC-1 combination therapy | Jessie Peh | 2025-06-24 |
| 12235275 | Fluorescent substrates for poly(ADP-ribosyl) hydrolases | Bryon S. Drown | 2025-02-25 |
| 12234240 | Substituted imidazo[5,1-d][1,2,3,5]tetrazines for the treatment of cancer | Timothy M. Fan, Riley L. SVEC | 2025-02-25 |
| 12180198 | Ribocil C antibiotics effective for Gram-negative pathogens | Emily Jane Geddes, Bryon S. Drown, Stephen E. Motika, Erica Parker | 2024-12-31 |
| 12180159 | Activators of the unfolded protein response | David J. Shapiro, Matthew Boudreau | 2024-12-31 |
| 12168006 | Cancer therapy by degrading dual MEK signaling | Jessie Peh, Matthew Boudreau | 2024-12-17 |
| 12090153 | Combination therapy for the treatment of uveal melanoma | Matthew Boudreau | 2024-09-17 |
| 11926877 | Saliva-based molecular testing for SARS-CoV-2 | Diana Rose Ranoa, Robin L. Holland, Fadi G. Alnaji, Kelsie J. Green, Leyi Wang +3 more | 2024-03-12 |
| 11858946 | Small molecules active against gram-negative bacteria | Michelle Richter, Andrew Riley, Bryon S. Drown, Martin Chavez, Sarah Tasker +1 more | 2024-01-02 |
| 11844798 | Procaspase combination therapy for glioblastoma | Rachel C. Botham, Timothy M. Fan, Mark J. GILBERT, Michael K. Handley, Avadhut Joshi +2 more | 2023-12-19 |
| 11833147 | Procaspase 3 activation by combination therapy | Rachel C. Botham, Timothy M. Fan, Mark J. GILBERT, Michael K. Handley, Howard S. Roth +1 more | 2023-12-05 |
| 11691967 | Antibiotics effective for gram-negative pathogens | Emily Jane Geddes, Bryon S. Drown, Stephen E. Motika, Erica Parker | 2023-07-04 |
| 11612598 | Compounds and methods for the treatment of cancer | Karson S. Putt, Quinn P. Peterson, Valerie Fako | 2023-03-28 |
| 11584718 | Activators of the unfolded protein response | David J. Shapiro, Matthew Boudreau | 2023-02-21 |
| 11530457 | Saliva-based molecular testing for SARS-CoV-2 | Diana Rose Ranoa, Robin L. Holland, Fadi G. Alnaji, Kelsie J. Green, Leyi Wang +3 more | 2022-12-20 |
| 11510919 | Cancer therapy by degrading dual MEK signaling | Jessie Peh, Matthew Boudreau | 2022-11-29 |
| 11274106 | Topoisomerase inhibitors with antibacterial and anticancer activity | Andrew Riley | 2022-03-15 |
| 11129830 | PAC-1 combination therapy | Jessie Peh | 2021-09-28 |
| 11046647 | Activators of the unfolded protein response | David J. Shapiro, Matthew Boudreau | 2021-06-29 |
| 10995097 | Small molecules active against gram-negative bacteria | Michelle Richter, Andrew Riley, Bryon S. Drown, Martin Chavez, Sarah Tasker +1 more | 2021-05-04 |
| 10918735 | Substituted pyrazino[1′,2′:1,5]pyrrolo[2,3-b]indole-1,4-diones for cancer treatment | Mohammad Movassaghi, Justin Kim, Karen Morrison, Nicolas Cedric Boyer | 2021-02-16 |
| 10888560 | Procaspase 3 activation by combination therapy | Rachel C. Botham, Timothy M. Fan, Mark J. GILBERT, Michael K. Handley, Howard S. Roth +1 more | 2021-01-12 |
| 10874666 | Procaspase combination therapy for glioblastoma | Rachel C. Botham, Timothy M. Fan, Mark J. GILBERT, Michael K. Handley, Avadhut Joshi +2 more | 2020-12-29 |
| 10800730 | Complex and structurally diverse compounds | Robert W. Huigens, III, Karen Morrison, Robert W. Hicklin, II, Timothy A. Flood, Jr. | 2020-10-13 |
| 10576096 | Tumor-selective combination therapy | David Boothman, Joseph S. Bair, Lifen Cao, Jinming Gao, Xiumei HUANG +4 more | 2020-03-03 |